{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T21:04:02Z","timestamp":1776978242408,"version":"3.51.4"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Pulmonary hypertension (PH) is a complication of multiple myeloma (MM); however, the clinical outcomes and prognosis are relatively not well known. We aimed to investigate the risk factors of transthoracic echocardiography-defined PH and its impact on the clinical outcome in patients with MM.<\/jats:p>\n            <jats:p>A retrospective study was performed using data from the Chonnam National University Hwasun Hospital database for patients who underwent transthoracic echocardiography (TTE) within 1 month of the MM diagnosis between January 2007 and December 2017. PH was defined as an estimated right ventricular systolic pressure (RVSP) &gt; 40\u00a0mmHg. A total of 390 patients were included. TTE-defined PH was observed in 107 patients (27%). During the follow-up period (median, 688 days), all-cause death was noted for 134 patients (34.4%). In the Kaplan-Meier survival analysis, the cumulative overall survival and cardiovascular death-free survival rates were significantly lower in the PH group than in the non-PH group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). In the propensity score-matched population, RVSP &gt; 40\u200ammHg on TTE and history of congestive heart failure (CHF) were identified as the significant independent predictors of all-cause and cardiovascular death.<\/jats:p>\n            <jats:p>This study reports that the prevalence of TTE-defined PH is higher in patients with MM than in the general population. Moreover, TTE-defined PH and a history of CHF are the independent prognostic factors for all-cause and cardiovascular death in patients with MM. These results highlight the risk of associated cardiovascular disease in patients with MM and emphasize the importance of management strategies that prevent the deterioration of cardiac function.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000022952","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T01:03:28Z","timestamp":1603501408000},"page":"e22952","source":"Crossref","is-referenced-by-count":5,"title":["Clinical impact of echocardiography-defined pulmonary hypertension on the clinical outcome in patients with multiple myeloma"],"prefix":"10.1097","volume":"99","author":[{"given":"SungA","family":"Bae","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine"},{"name":"Division of Cardiology, Anam Hospital, Korea University College of Medicine, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kye Hun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine"},{"name":"Translational Research Center on Aging, Chonnam National University Hospital, Gwangju"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Ju","family":"Yoon","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine"},{"name":"Translational Research Center on Aging, Chonnam National University Hospital, Gwangju"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung Yoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyukjin","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Yeong","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Chul","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongcheol","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Joon","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung Wook","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju Han","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youngkeun","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung Ho","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Gwan","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Chun","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine"},{"name":"Translational Research Center on Aging, Chonnam National University Hospital, Gwangju"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"R1-20230916","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","article-title":"Multiple myeloma","volume":"111","author":"Kyle","year":"2008","journal-title":"Blood"},{"key":"R2-20230916","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"R3-20230916","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12185-010-0617-6","article-title":"Multiple myeloma in Korea: past, present, and future perspectives. Experience of the Korean Multiple Myeloma Working Party","volume":"92","author":"Lee","year":"2010","journal-title":"Int J Hematol"},{"key":"R4-20230916","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies","volume":"111","author":"Kumar","year":"2008","journal-title":"Blood"},{"key":"R5-20230916","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10238-008-0169-8","article-title":"Long-term survival in multiple myeloma: a single-center experience","volume":"8","author":"Merchionne","year":"2008","journal-title":"Clin Exp Med"},{"issue":"(25 Suppl)","key":"R6-20230916","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R7-20230916","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF02936537","article-title":"An unusual case of pulmonary hypertension in a young male","volume":"1","author":"Rostagno","year":"2006","journal-title":"Intern Emerg Med"},{"key":"R8-20230916","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.ijcard.2006.07.059","article-title":"Pulmonary hypertension as a dominant clinical picture in a case of amyloidosis and smoldering multiple myeloma","volume":"115","author":"Lehtonen","year":"2007","journal-title":"Int J Cardiol"},{"key":"R9-20230916","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ajh.20416","article-title":"Pulmonary veno-occlusive disease as a cause for reversible pulmonary hypertension in a patient with multiple myeloma undergoing peripheral blood stem cell transplantation","volume":"80","author":"Malhotra","year":"2005","journal-title":"Am J Hematol"},{"key":"R10-20230916","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1086\/679726","article-title":"Severe reversible pulmonary hypertension in smoldering multiple myeloma: two cases and review of the literature","volume":"5","author":"Feyereisn","year":"2015","journal-title":"Pulm Circ"},{"key":"R11-20230916","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1365-2141.2005.05389.x","article-title":"Pulmonary hypertension and thalidomide therapy in multiple myeloma","volume":"128","author":"Hattori","year":"2005","journal-title":"Br J Haematol"},{"key":"R12-20230916","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1538-7836.2011.04215.x","article-title":"Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis","volume":"9","author":"Carrier","year":"2011","journal-title":"J Thromb Haemost"},{"key":"R13-20230916","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1161\/hc4801.100076","article-title":"Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects","volume":"104","author":"McQuillan","year":"2001","journal-title":"Circulation"},{"key":"R14-20230916","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"R15-20230916","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"R16-20230916","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/ejechocard\/jep007","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography","volume":"10","author":"Nagueh","year":"2009","journal-title":"Eur J Echocardiogr"},{"key":"R17-20230916","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2011.01.015","article-title":"Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE\/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography","volume":"24","author":"Mor-Avi","year":"2011","journal-title":"J Am Soc Echocardiogr"},{"key":"R18-20230916","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/CIRCIMAGING.109.862334","article-title":"Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring","volume":"2","author":"Stanton","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"key":"R19-20230916","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.echo.2007.01.005","article-title":"Reappraisal of the use of inferior vena cava for estimating right atrial pressure","volume":"20","author":"Brennan","year":"2007","journal-title":"J Am Soc Echocardiogr"},{"key":"R20-20230916","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1136\/heartjnl-2012-301992","article-title":"Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort","volume":"98","author":"Strange","year":"2012","journal-title":"Heart"},{"key":"R21-20230916","doi-asserted-by":"crossref","first-page":"e0130072","DOI":"10.1371\/journal.pone.0130072","article-title":"Prevalence of pulmonary hypertension in the general population: the rotterdam study","volume":"10","author":"Moreira","year":"2015","journal-title":"PLoS One"},{"key":"R22-20230916","doi-asserted-by":"crossref","first-page":"282","DOI":"10.14423\/SMJ.0000000000000461","article-title":"Echocardiography-defined pulmonary hypertension in multiple myeloma: risk factors and impact on outcomes","volume":"109","author":"Sangani","year":"2016","journal-title":"South Med J"},{"key":"R23-20230916","first-page":"919","article-title":"Properties of IgA myeloma proteins isolated rom sera of patients with the hyperviscosity syndrome","volume":"89","author":"Mestecky","year":"1977","journal-title":"J Lab Clin Med"},{"key":"R24-20230916","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2141.2006.06208.x","article-title":"Acquired resistance to activated protein C (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolism","volume":"134","author":"Elice","year":"2006","journal-title":"Br J Haematol"},{"key":"R25-20230916","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2007-976169","article-title":"Hemostatic dysfunction in paraproteinemias and amyloidosis","volume":"33","author":"Zangari","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"R26-20230916","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jacc.2011.06.076","article-title":"Pulmonary pressures and death in heart failure: a community study","volume":"59","author":"Bursi","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R27-20230916","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ejheart.2004.10.021","article-title":"Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure","volume":"7","author":"Delgado","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"R28-20230916","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/bjc.2014.307","article-title":"The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma","volume":"111","author":"Wu","year":"2014","journal-title":"Br J Cancer"},{"key":"R29-20230916","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/leu.2010.192","article-title":"Insulin is a potent myeloma cell growth factor through insulin\/IGF-1 hybrid receptor activation","volume":"24","author":"Sprynski","year":"2010","journal-title":"Leukemia"},{"key":"R30-20230916","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1182\/blood-2011-10-386789","article-title":"Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma","volume":"120","author":"Kuhn","year":"2012","journal-title":"Blood"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022952","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T03:47:09Z","timestamp":1694836029000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":30,"journal-issue":{"issue":"43","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000022952","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,23]]}}}